Reaction Details Report a problem with these data
Target
Fatty acid-binding protein, intestinal
Ligand
BDBM13066
Substrate
n/a
Meas. Tech.
Fluorophore Displacement Assay
Temperature
566.3±0 K
Ki
8.63e+4± 5e+1 nM
Citation
 Patil, R; Laguerre, A; Wielens, J; Headey, SJ; Williams, ML; Hughes, ML; Mohanty, B; Porter, CJ; Scanlon, MJ Characterization of two distinct modes of drug binding to human intestinal fatty acid binding protein. ACS Chem Biol 9:2526-34 (2014) [PubMed]  Article 
Target
Name:
Fatty acid-binding protein, intestinal
Synonyms:
FABP2 | FABPI | FABPI_HUMAN | Fatty acid binding protein intestinal | Fatty acid-binding protein, intestinal | I-FABP | Intestinal fatty acid-binding protein (hIFABP)
Type:
Protein
Mol. Mass.:
15207.56
Organism:
Homo sapiens (Human)
Description:
n/a
Residue:
132
Sequence:
MAFDSTWKVDRSENYDKFMEKMGVNIVKRKLAAHDNLKLTITQEGNKFTVKESSAFRNIEVVFELGVTFNYNLADGTELRGTWSLEGNKLIGKFKRTDNGNELNTVREIIGDELVQTYVYEGVEAKRIFKKD
  
Inhibitor
Name:
BDBM13066
Synonyms:
2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid | CHEMBL139 | Diclofenac | US11337935, Compound Diclofenac | US11478464, Compound Diclofenac | US11786535, Compound Diclofenac | {2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid
Type:
Small organic molecule
Emp. Form.:
C14H11Cl2NO2
Mol. Mass.:
296.149
SMILES:
OC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl
Structure:
Search PDB for entries with ligand similarity: